TRxADE Health (NASDAQ: MEDS), a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the United States, has partnered with its digital healthcare subsidiary Bonum Health to announce a new service: televeterinary services for pets. According to the announcement, Bonum Health, which provides nationwide telemedicine services for humans, has created a digital veterinary clinic. Available in limited markets, the innovative new approach offers telephone consultations with professional veterinarians who provide services for cats and dogs. According to the company, this new service complements a vision shared by both TRxADE and Bonum Health of delivering more viable pet-health options and adding greater value to its household subscriber platform. “We are excited to add tele-vet to our fast-growing telemedicine platform,” said Bonum Health president Ashton Maaraba in the press release. “Over the years, we found significant demand in this space, and as we studied the benefit and growth potential of this new model, it became evident to us that we needed to pursue it. We plan on launching in limited markets as this provides us the opportunity to scale and expand our care services beyond cats and dogs, while studying the required capacity to keep up with demand. We believe that our vet clinic has the potential for significant growth.”
To view the full press release, visit https://ibn.fm/6Xnvs
About TRxADE Health Inc
TRxADE Health is a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the United States. The company operates the TRxADE drug procurement marketplace serving more than 13,475 members nationwide, fostering price transparency and, under the Bonum Health brand, offering patient-centric telehealth services. For more information about the company, please visit www.Trxade.com and www.BonumHealth.com.
NOTE TO INVESTORS: The latest news and updates relating to MEDS are available in the company’s newsroom at http://ibn.fm/MEDS
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.
As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]
InvestorWire is part of the InvestorBrandNetwork.